EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, TBIO: Telesis Bio Inc

23 Dec 2025
LAST:

0.1100

CHANGE:
 0.00		OPEN:
0.1100		HIGH:
0.1100		ASK:
0.0000		VOLUME:
900
CHG(%):
0.00		PREV:
0.1100		LOW:
0.1000		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Dec 250.11000.11000.10000.1100900
19 Dec 250.11000.15000.11000.110015.9K
18 Dec 250.01300.01300.01300.0130200
15 Dec 250.00300.00300.00300.00301.0K
11 Dec 250.02100.02100.02100.02101.0K
10 Dec 250.02100.02100.02100.0210700
08 Dec 250.00300.00300.00300.00301.5K
05 Dec 250.02200.02200.02200.0220100

PROFILE

Name:Telesis Bio Inc
About:Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice, as well as mRNA constructs; and BioXp De Novo kits, which contains building blocks and reagents, including proprietary Gibson assembly branded reagents for specific synthetic biology workflow applications. It also provides BioXp Select kits that offers to use non-telesis bio DNA while using the BioXp system to perform synthetic biology workflow applications, such as cloning, mRNA generation from plasmid, and cell free amplification; BioXp Next Generation Sequencing kits, which contains reagents to go from DNA or RNA to a sequencer-ready library; Benchtop reagents that contains the reagents to proceed specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and custom Gibson short oligo ligation assembly enzymatic DNA synthesis solutions, which is designed to construct synthetic DNA, RNA, and proteins for development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines. It has license agreement with Regeneron Pharmaceuticals, Inc. The company serves its products to government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as Codex DNA, Inc. and changed its name to Telesis Bio Inc. in November 2022. Telesis Bio, Inc. was incorporated in 2011 and is headquartered in San Diego, California.
Sector:Healthcare
Address:10431 Wateridge Circle, San Diego, CA, United States, 92121-2993
Website:https://telesisbio.com
CIK:0001850079
ISIN:US1920032000
FIGI:BBG011363VM3

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.05114.0%
MA10:0.03218.8%
MA20:0.03340.0%
MA50:0.111.9%
MA100:0.28153.7%
STO9:72.79
STO14:72.79
RSI14:78.49 
MTM14:0.09
ROC14:4.24 
ATR:0.02 
Week High:0.1536.4%
Week Low:0.01746.2%
Month High:0.1536.4%
Month Low:0.00
Volatility:680.57